new glp 1 coming out Five Unexpected Uses for GLP-1 Receptor Agonists January 2026: New or Expanded

doi: 10.1093/jas/skaf192 125 TrevisiE.AmadoriM.CogrossiS.RazzuoliE.BertoniG

Lyophilized Storage Store below -18C, stable up to 24 months

Call the office in Roseville or Lincoln, California, at 916-253-9996 to discuss GLP-1 medications, or complete the online inquiry form

2,3 REDEFINE 1 was a 68-week, double-blind, randomized, placebo- and active-controlled phase 3 trial that evaluated the efficacy and safety of once-weekly CagriSema versus cagrilintide 2.4 mg monotherapy, semaglutide 2.4 mg monotherapy, and placebo, all in combination with lifestyle intervention in 3,417 adults with obesity or overweight with one or more obesity-related complications and without type 2 diabetes